PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis c |
| Symptom | |liver fibrosis |
| Sentences | 98 |
| PubMedID- 21971536 | Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 20002560 | Transient elastometry (te) could provide a more accurate evaluation of the frequency and risk factors of liver fibrosis in hepatitis c virus (hcv) infection than that based on biopsy. |
| PubMedID- 20963316 | Hyaluronic acid in the evaluation of liver fibrosis in patients with hepatitis c on haemodialysis. |
| PubMedID- 19922441 | A simple, noninvasive test for the diagnosis of liver fibrosis in patients with hepatitis c recurrence after liver transplantation. |
| PubMedID- 22110596 | We evaluated whether adiponectin level was associated with the prevalence and histological grade of hepatocellular carcinoma (hcc), and liver fibrosis in patients with hepatitis c virus (hcv) infection. |
| PubMedID- 24209497 | It has been shown that marijuana use may correlate with the progression of liver fibrosis in patients with hepatitis c. |
| PubMedID- 23845056 | Regulation of tsp-1 with regards to its influence on tgf-β1 activity may be one of the causes of fibrosis, as tgf-β1 positively regulates hcv rna replication which is likely manifested in the liver fibrosis associated with hepatitis c infection . |
| PubMedID- 19850017 | Automation of the hepascore and validation as a biochemical index of liver fibrosis in patients with chronic hepatitis c from the anrs hc ep 23 fibrostar cohort. |
| PubMedID- 24023984 | Aim: to evaluate serum complement c4a and its relation to liver fibrosis in children with chronic hepatitis c virus (hcv) infection. |
| PubMedID- 23245820 | Factors which influence the accuracy of acoustic radiation force impulse (arfi) elastography for the diagnosis of liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 22070853 | Single stage and multistage classification models for the prediction of liver fibrosis degree in patients with chronic hepatitis c infection. |
| PubMedID- 20723207 | Background: hyaluronic acid (ha) serum levels correlate with the histological stages of liver fibrosis in hepatitis c virus (hcv) monoinfected patients, and ha alone has shown very good diagnostic accuracy as a non-invasive assessment of fibrosis and cirrhosis. |
| PubMedID- 22138553 | Hepatic safety of efavirenz in hiv/hepatitis c virus-coinfected patients with advanced liver fibrosis. |
| PubMedID- 20698740 | liver fibrosis in hepatitis c patients of pakistani versus scandinavian origin. |
| PubMedID- 22140539 | We have shown that two isoforms of fibronectin reflect the severity of liver fibrosis in patients with chronic hepatitis c raising the possibility that fibronectin itself may play a role in the pathogenesis of fibrosis 9. |
| PubMedID- 24946280 | Background & aims: there is little information regarding the extent to which difficult to cure patients with advanced liver fibrosis, due to hepatitis c virus genotype-1 (hcv-1) can successfully and safely be treated with triple therapy with telaprevir (tvr), pegylated interferon alpha (p) and ribavirin (r). |
| PubMedID- 23142332 | Discordance among transient elastography, aspartate aminotransferase to platelet ratio index, and histologic assessments of liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 20630109 | Novel biomarkers predict liver fibrosis in hepatitis c patients: alpha 2 macroglobulin, vitamin d binding protein and apolipoprotein ai. |
| PubMedID- 22138940 | The limitations of and the invasive nature of liver biopsy has spurred extensive interest in the development of non-invasive tests to measure liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 22035045 | Conclusions: safe biopsy and the fibropaca algorithm have excellent performance for liver fibrosis in hepatitis c, allowing a significant reduction in the need for liver biopsies. |
| PubMedID- 26214180 | Predictive ability of laboratory indices for liver fibrosis in patients with chronic hepatitis c after the eradication of hepatitis c virus. |
| PubMedID- 22535703 | Assessment of liver fibrosis in patients with chronic hepatitis c (chc) is critical for predicting disease progression and determining future antiviral therapy. |
| PubMedID- 24324779 | Several studies have reported that cigarette smoking accelerates the progression of liver fibrosis in patients with chronic hepatitis c , and typical inflammatory biomarkers such as crp and fibrinogen are elevated in smokers . |
| PubMedID- 19732322 | Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in hiv/hepatitis c virus-coinfected patients and correlation with noninvasive serum markers. |
| PubMedID- 24957365 | In turn, insulin resistance in chronic hepatitis c is associated with progression of liver fibrosis, resistance to antiviral therapy and development of hepatocellular carcinoma. |
| PubMedID- 21889468 | Relative performances of fibrotest, fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis c: a step toward the truth in the absence of a gold standard. |
| PubMedID- 24926259 | Chronic hepatitis c patients with advanced liver fibrosis are at risk for hepatocellular carcinoma (hcc). |
| PubMedID- 21468012 | Objectives: precise evaluation of the level of liver fibrosis is recommended in patients with chronic hepatitis c (chc). |
| PubMedID- 26140381 | Opioid use and risk of liver fibrosis in hiv/hepatitis c virus-coinfected patients in canada. |
| PubMedID- 20802942 | This study had the objective of independently assessing the relationship between previous hepatitis b infection and liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 24245909 | Progression of liver fibrosis in hiv/hepatitis c virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline. |
| PubMedID- 22162013 | Diagnostic algorithms for liver fibrosis in hepatitis c: are they ready to avoid liver biopsy. |
| PubMedID- 23085648 | Background & aims: the progression of liver fibrosis in patients with chronic hepatitis c (chc) is important to decide on the treatment of the virus. |
| PubMedID- 25545640 | Objective: liver fibrosis has been associated with hepatitis c virus (hcv) genotype and genetic variation near the interleukin 28b (il28b) gene, but the relative contribution is unknown. |
| PubMedID- 23269016 | Purpose: we evaluated the use of magnetic resonance (mr) elastography (mre) for staging liver fibrosis in patients with chronic hepatitis c and compared the ability of mre and serum fibrosis markers for discriminating each stage of fibrosis. |
| PubMedID- 26245999 | Presented approach is used to recognize liver fibrosis stage of patients with hepatitis c virus (hcv) infection. |
| PubMedID- 23112543 | Liver biopsy (lb) has traditionally been considered the gold standard for pretreatment evaluation of liver fibrosis in patients with chronic hepatitis c (chc). |
| PubMedID- 26356792 | The performance of fibroscan® (echosens, paris, france) in particular has been widely validated in the assessment of liver fibrosis in patients with chronic hepatitis c virus infection, leading to further studies evaluating its utility in ald. |
| PubMedID- 22959098 | Performances of elasto-fibrotest((r)), a combination between fibrotest((r)) and liver stiffness measurements for assessing the stage of liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 23301544 | Serum bile acid levels as a predictor for the severity of liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 26180854 with Chronic Hepatitis B and C: A Review of Diagnostic Accuracy, Clinical Effectiveness, Cost-Effectiveness and Guidelines | This report represents a pseudo update to a previous 2012 report that reviewed the clinical and cost-effectiveness evidence of diagnosis and monitoring of liver fibrosis among patients with chronic hepatitis c. |
| PubMedID- 20356387 | Serum atx activity and plasma lpa level were increased in chronic hepatitis c in association with liver fibrosis . |
| PubMedID- 21735832 | Assessment of liver fibrosis in patients with chronic hepatitis c (chc) is essential for determination of prognosis, monitoring of the disease and guiding therapeutic decisions. |
| PubMedID- 20868448 | As hiv dysregulates transforming growth factor-beta1 (tgf-beta1) and t regulatory (treg) cells, both of which are involved in hepatic fibrogenesis, herein we describe their influence on liver fibrosis staging in patients with chronic hepatitis c with and without hiv coinfection. |
| PubMedID- 23078008 | K8/k18 variants are not only overrepresented in subjects with multiple liver disorders, but also predispose to liver fibrosis development in patients with chronic hepatitis c and primary biliary cirrhosis as well as to adverse outcome of acute liver failure. |
| PubMedID- 23941979 | Background/aim: the aim of this work was to establish an association between the single-nucleotide polymorphisms (snps) of tgfb1 (rs1800471), at (rs3789679), mmp-1 (rs17886084), mmp-3 (rs35068180), and pai-1 (rs1799889) and the histological grading of necroinflammation, staging of hepatic fibrosis, and liver function in mexican patients with advanced liver fibrosis due to chronic hepatitis c virus infection. |
| PubMedID- 26450804 | Ultimately, sustained virological response to hepatitis c therapy is associated with liver fibrosis regression in patients with hiv/hcv coinfection. |
| PubMedID- 22235211 | Noninvasive evaluation of liver fibrosis in patients with chronic hepatitis c. |
Page: 1 2